A ruling tossing Connecticut-based OxyContin maker Purdue Pharma's bankruptcy settlement could tee up a new issue for the U.S. Supreme Court and spur other judges to more closely scrutinize controversial non-debtor releases, which shield third parties from liability in Chapter 11 proceedings.